REFERENCES
- Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of
spinal muscular atrophy: Part 1: Recommendations for diagnosis,
rehabilitation, orthopedic and nutritional care. Neuromuscul Disord.
2018;28(2):103-115.
- Finkel RS, Mercuri E, Meyer OH, et al. Diagnosis and management of
spinal muscular atrophy: Part 2: Pulmonary and acute care;
medications, supplements and immunizations; other organ systems; and
ethics. Neuromuscul Disord. 2018;28(3):197-207.
- Chacko A, Sly PD, Gauld L. Polysomnography findings in pediatric
spinal muscular atrophy types 1-3. Sleep Med. 2020;68: 124-130.
- Mannaa MM, Kalra M, Wong B, et al. Survival probabilities of patients
with childhood spinal muscle atrophy. J Clin Neuromuscul Dis.
2009;10(3): 85-89.
- Allergy group of Chinese association of pediatricians, Respiration
group of Chinese medical association of pediatrics, Rheumatology and
immunology group of Chinese association of pediatricians, et al.
Clinical diagnosis and treatment path of recurrent respiratory tract
infection in children (2022 edition). Chinese Journal of Practical
Pediatrics. 2022;37(3):161-168.
- Bradley JS, Byington CL, Shah SS, et al. The management of
community-acquired pneumonia in infants and children older than 3
months of age: clinical practice guidelines by the Pediatric
Infectious Diseases Society and the Infectious Diseases Society of
America. Clin Infect Dis. 2011;53(7):e25-e76.
- Berry RB, Brooks R, Gamaldo CE, et al. The AASM Manual for Scoring of
Sleep and Associated Events: Rules, Terminology and Technical
Specifications, Version 2.3. Darien, Illinois: American Academy of
Sleep Medicine, 2016.
- World Health Organization. WHO child growth standards:
length/height-for-age, weight-for-age, weight-for-length,
weight-for-height and body mass index-for-age: methods and
development. Geneva: WHO Press. 2006.
- Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the
United States: methods and development. National Center for Health
Statistics. Vital Health Stat 11(246).2002.
- Aguerre V, De Castro F, Mozzoni J, et al. Natural History of Type 1
Spinal Muscular Atrophy in a Series of Argentinian Children. J
Neuromuscul Dis. 2020;7(4):453-458.
- Pane M, Palermo C, Messina S, et al. An observational study of
functional abilities in infants, children, and adults with type 1 SMA.
Neurology. 2018;91(8):e696-e703.
- Mercuri E, Lucibello S, Pera MC, et al. Long-term progression in type
II spinal muscular atrophy: A retrospective observational study.
Neurology. 2019;93(13):e1241-e1247.
- Qu YJ, Ge XS, Bai JL, et al. Association of copy numbers of survival
motor neuron gene 2 and neuronal apoptosis inhibitory protein gene
with the natural history in a Chinese spinal muscular atrophy cohort.
J Child Neurol. 2015;30(4):429-436.
- Moore GE, Lindenmayer AW, McConchie GA, et al. Describing nutrition in
spinal muscular atrophy: A systematic review. Neuromuscul Disord.
2016;26(7):395-404.
- McGrattan KE, Graham RJ, DiDonato CJ, et al. Dysphagia phenotypes in
spinal muscular atrophy: The past, present, and promise for the
future. Am J Speech Lang Pathol. 2021;30(3):1008-1022.
- Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline
for diagnostic testing for adult obstructive sleep apnea: an American
Academy of Sleep Medicine clinical practice guideline. J Clin Sleep
Med. 2017;13(3):479-504.
- Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of
Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone
health, and orthopaedic management. Lancet Neurol. 2018;17(4):347-361.
- Pera MC, Romeo DM, Graziano A, et al. Sleep disorders in spinal
muscular atrophy.Sleep Med. 2017;30(2):160-163.
- Trucco F, Pedemonte M, Fiorillo C, et al. Detection of early nocturnal
hypoventilation in neuromuscular disorders. J Int Med Res.
2018;46(3):1153-1161.
- BertrĂ¡n K, Sans Capdevila O, Nascimiento A, et al. Sleep breathing
disorders in pediatric patients with spinal muscular atrophy 2. Sleep
Med. 2022;89:85-89.
- AlBalawi MM, Castro-Codesal M, Featherstone R, et al. Outcomes of
Long-Term Noninvasive Ventilation Use in Children with Neuromuscular
Disease: Systematic Review and Meta-Analysis. Ann Am Thorac Soc.
2022;19(1):109-119.
- Veldhoen ES, Wijngaarde CA, Hulzebos EHJ, et al. Natural history of
respiratory muscle strength in spinal muscular atrophy: a prospective
national cohort study. Orphanet J Rare Dis. 2022;17(1):70.
- Trucco F, Ridout D, Scoto M, et al. Respiratory Trajectories in Type 2
and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study. Neurology.
2021;96(4):e587-e599.
- American Academy of Sleep Medicine. International classification of
sleep disorders, 3rd ed. Darien, IL: American
Academy of Sleep Medicine, 2014.
- Won YH, Choi WA, Lee JW, et al. Sleep Transcutaneous vs. End-Tidal
CO2 Monitoring for Patients with Neuromuscular
Disease. Am J Phys Med Rehabil. 2016;95(2):91-95.
- Menard J, Seferian AM, Fleurence E, et al. Respiratory management of
spinal muscular atrophy type 1 patients treated with nusinersen.
Pediatr Pulmonol. 2022;Mar 20.
- Chacko A, Sly PD, Ware RS, et al. Effect of nusinersen on respiratory
function in paediatric spinal muscular atrophy types 1-3. Thorax.
2022;77(1):40-46.
- Heitschmidt L, Pichlmaier L, Eckerland M, et al. Nusinersen does not
improve lung function in a cohort of children with spinal muscular
atrophy - A single-center retrospective study. Eur J Paediatr Neurol.
2021;31:88-91.
- Lavie M, Diamant N, Cahal M, et al. Nusinersen for spinal muscular
atrophy type 1: Real-world respiratory experience. Pediatr Pulmonol.
2021;56(1):291-298.
- Ou SF, Ho CS, Lee WT, et al. Natural history in spinal muscular
atrophy Type I in Taiwanese population: A longitudinal study. Brain
Dev. 2021;43(1):127-134.
- Gregoretti C, Ottonello G, Chiarini Testa MB, et al. Survival of
patients with spinal muscular atrophy type 1. Pediatrics.
2013;131(5):e1509-e1514.